Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing
Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug
Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35